For these reasons, it is essential to avoid hypoglycemia during HHC, and it is recommended that glucose should not be lowered below 200–300 mg/dL during the first few hours of treatment [1], which takes place during the initial intravenous insulin therapy phase (IIITP). This evidence concerns the gene INS and Hypoglycemia.